Homology Medicines Inc
Change company Symbol lookup
Select an option...
FIXX Homology Medicines Inc
APAM Artisan Partners Asset Management Inc
TQQQ ProShares UltraPro QQQ
AVCT American Virtual Cloud Technologies Inc
LITM Snow Lake Resources Ltd
SJ Scienjoy Holding Corp
PBTS Powerbridge Technologies Co Ltd
DRTT DIRTT Environmental Solutions Ltd
LVTX LAVA Therapeutics NV
AGNPF Algernon Pharmaceuticals Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Homology Medicines, Inc. is a clinical-stage genetic medicines company focused on providing treatment for rare genetic diseases. The Company’s clinical programs include HMI-102, is an investigational gene therapy candidate in clinical development for the treatment of adult patients with phenylketonuria (PKU); HMI-103, which is an investigational gene editing candidate in clinical development for the treatment of patients with PKU, and HMI-203, which is an investigational gene therapy candidate in clinical development for the treatment of patients with mucopolysaccharidosis type II (MPS II), or Hunter syndrome. Additionally, the Company is developing a gene therapy candidate, HMI-104, from its GTx-mAb platform for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH), and conducting research in other diseases, including metachromatic leukodystrophy (MLD). Its platform is designed to utilize human hematopoietic stem cell derived adeno-associated virus vectors.

Closing Price
$1.52
Day's Change
-0.03 (-1.94%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.62
Day's Low
1.51
Volume
(Light)
Volume:
140,198

10-day average volume:
258,067
140,198

Thinking about trading options or stock in Sarepta Therapeutics, Apple, General Electric, Microsoft, or Meta Platforms?

9:39 am ET July 29, 2022 (PR Newswire) Print

InvestorsObserver issues critical PriceWatch Alerts for SRPT, AAPL, GE, MSFT, and META.

https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report - Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast.

-- SRPT: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=SRPT&prnumber=072920223

-- AAPL: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=AAPL&prnumber=072920223

-- GE: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=GE&prnumber=072920223

-- MSFT: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=MSFT&prnumber=072920223

-- META: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=META&prnumber=072920223

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

https://c212.net/c/img/favicon.png?sn=CG31228&sd=2022-07-29

View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-sarepta-therapeutics-apple-general-electric-microsoft-or-meta-platforms-301596142.html

SOURCE InvestorsObserver

https://rt.prnewswire.com/rt.gif?NewsItemId=CG31228&Transmission_Id=202207290939PR_NEWS_USPR_____CG31228&DateId=20220729

comtex tracking

COMTEX_411233010/1005/2022-07-29T09:39:10

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.